Sorrento Therapeutics Investor

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Technology: CAR-T, Cell_Therapies, RNA
Industry: CAR-T, RNA
Headquarters: San Diego, California, United States
Founded Date: 2006-01-01
Employees Number: 101-250
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: 1
Acquisitions Number: Made Acquisitions
Investors Number: 1
Total Funding: 185718495
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-10-09
Last Funding Type: Post-IPO Equity

Visit Website
info@sorrentotherapeutics.com
Register and Claim Ownership